Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (M... von Rose, Tracy L, Harrison, Michael Roger, Deal, Allison Mary, Osterman, Chelsea K., Ramalingam, Sundhar, Whang, Young E., Brower, Blaine Y, Bjurlin, Marc, Smith, Angela B., Nielsen, Matthew E., Tan, Hung-Jui, Wallen, Eric M., George, Daniel J., Zhang, Tian, Drier, Anthony, Kim, William Y., Milowsky, Matthew I.

Volltext

Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer von Rose, Tracy L, Hayward, Michele C, Salazar, Ashley H, Eulitt, Patrick, McGinty, Katrina, Drier, Anthony, Wobker, Sara Elizabeth, Whang, Young E., Brower, Blaine Y, Dunn, Mary, Crona, Daniel James, Shibata, Yoichiro, Uronis, Joshua M, Mayhew, Gregory, Milowsky, Matthew I., Kim, William Y.

Volltext

Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer von Rose, Tracy L, Harrison, Michael R, Deal, Allison M, Ramalingam, Sundhar, Whang, Young E, Brower, Blaine, Dunn, Mary, Osterman, Chelsea K, Heiling, Hillary M, Bjurlin, Marc A, Smith, Angela B, Nielsen, Matthew E, Tan, Hung-Jui, Wallen, Eric, Woods, Michael E, George, Daniel, Zhang, Tian, Drier, Anthony, Kim, William Y, Milowsky, Matthew I

Volltext